This is a research study looking into an investigational vaccine for respiratory syncytial virus (RSV) that involves people 65 years of age or over. RSV is a common virus that usually produces mild, cold-like symptoms. Whilst recovery can be quick, RSV is one of the most common causes of acute respiratory disease and is becoming increasingly recognized as a major cause of serious illness in older adults. Recent studies have shown that RSV infection develops in up to 10 percent of high-risk individuals and in 7 percent of healthy adults.
There is no vaccine on the market that is currently available to protect against RSV. Like influenza, RSV is typically a seasonal disease and this study is researching the possibility of an RSV vaccine being administered at the same time as the seasonal influenza vaccine.
If eligible to take part, the study would require you to come to the clinic 3 times over a 2-month period. Visits will range between 15 minutes to an hour each time you come in. Over the course of the study, we will check your medical history, take your bloods and administer the vaccines about one month apart. You will also need to complete an e-diary for 7 days after each vaccination recording any symptoms you may experience.
You will be reimbursed for your time and involvement in the research study.
- Aged 65 or over
- Is not immunocompromised